Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H27N5O3 |
InChIKeyQTHRXIUTSUVNPH-UHFFFAOYSA-N |
CAS Registry2059892-29-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 10 Nov 2016 |